Back to News
Market Impact: 0.4

Revvity (RVTY) Surpasses Q2 Earnings and Revenue Estimates

RVTYSPYSKINNDAQ
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesAnalyst InsightsHealthcare & BiotechInvestor Sentiment & Positioning
Revvity (RVTY) Surpasses Q2 Earnings and Revenue Estimates

Revvity (RVTY) reported adjusted Q2 2025 earnings of $1.18 per share, surpassing the Zacks Consensus Estimate of $1.14, despite being down from $1.22 a year ago. Quarterly revenues reached $720.28 million, exceeding the $711.17 million consensus and up from $691.68 million year-over-year. While the company has consistently beaten EPS and revenue estimates in recent quarters, its shares have underperformed the S&P 500 year-to-date, with a current Zacks Rank #3 (Hold) indicating a market-perform expectation, contingent on management's future guidance.

Analysis

Revvity (RVTY) reported a solid operational quarter, surpassing consensus estimates on both its top and bottom lines for Q2 2025. The company posted adjusted earnings of $1.18 per share, a 3.51% beat over the $1.14 estimate, and revenues of $720.28 million, which was 1.27% above consensus. This performance extends a consistent trend of outpacing expectations, marking the fourth consecutive EPS beat. However, key counterpoints temper this positive result: adjusted EPS declined from $1.22 in the prior-year period, suggesting potential margin pressure despite a 4.1% year-over-year revenue increase from $691.68 million. The market has remained skeptical, with RVTY's shares down 7.1% year-to-date, starkly underperforming the S&P 500's 8.6% gain. The current Zacks Rank #3 (Hold) rating reflects this mixed picture, indicating an expectation for market-inline performance until further catalysts emerge. The future trajectory heavily depends on management's guidance and subsequent analyst estimate revisions, which will be critical in determining if the stock can reverse its underperformance.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo